{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"bioRxiv"}],"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T14:14:43Z","timestamp":1785420883493,"version":"3.56.0"},"posted":{"date-parts":[[2026,3,23]]},"group-title":"Neuroscience","reference-count":51,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.biorxiv.org\/about\/FAQ#license"}],"funder":[{"award":["NS129188"],"award-info":[{"award-number":["NS129188"]}],"id":[{"id":"https:\/\/ror.org\/001d55x84","id-type":"ROR","asserted-by":"publisher"}]},{"award":["NS127391"],"award-info":[{"award-number":["NS127391"]}],"id":[{"id":"https:\/\/ror.org\/001d55x84","id-type":"ROR","asserted-by":"publisher"}]},{"name":"US Collaborative Research Project","award":["RS-2024-00468036"],"award-info":[{"award-number":["RS-2024-00468036"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,3,23]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:p>\n                  The nuclear receptor Nurr1 (NR4A2) is an essential transcription factor that governs the differentiation, maturation, and long-term maintenance of midbrain dopaminergic (mDA) neurons in the substantia nigra. Reduced Nurr1 expression has been closely linked to age-related dopaminergic neuronal loss and the pathogenesis of Parkinson\u2019s disease. However, the molecular mechanisms regulating Nurr1 expression and protein stability in the aging midbrain remain poorly understood. Here, we identify Janus kinase 2 (JAK2) as a previously unrecognized regulator of Nurr1 in mDA neurons. In the substantia nigra of aged mice (12-and 18-month-old), JAK2 was robustly expressed in Nurr1-positive mDA neurons, whereas its expression was minimal in young adult mice. In SK-N-BE(2)C neuroblastoma cells, overexpression of JAK2 modestly enhanced Nurr1 transcriptional activity, while the constitutively active mutant JAK2\n                  <jats:sub>V617F<\/jats:sub>\n                  markedly increased it. Notably, this effect was not blocked by pharmacological inhibition of STAT, PI3K, or Akt signaling pathways, indicating that JAK2 regulates Nurr1 independently of canonical JAK\/STAT or PI3K\/Akt signaling. Mechanistically, JAK2 did not promote tyrosine phosphorylation of Nurr1 but instead physically interacted with Nurr1, leading to enhanced nuclear stability of the Nurr1 protein. Consistent with this mechanism, expression of JAK2\n                  <jats:sub>V617F<\/jats:sub>\n                  increased Nurr1 protein levels without altering its mRNA expression. Functionally, co-expression of JAK2\n                  <jats:sub>V617F<\/jats:sub>\n                  and Nurr1 attenuated oxidative stress\u2013induced cytotoxicity and reduced reactive oxygen species accumulation. Together, these findings reveal a phosphorylation-independent mechanism by which JAK2 stabilizes Nurr1 protein and enhances its transcriptional activity. Our results further suggest that age-associated induction of JAK2 in dopaminergic neurons may promote neuronal resilience by maintaining Nurr1 protein stability during aging.\n                <\/jats:p>","DOI":"10.64898\/2026.03.19.712974","type":"posted-content","created":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T23:15:23Z","timestamp":1774307723000},"source":"Crossref","is-referenced-by-count":0,"title":["Janus kinase 2 regulates Nurr1 protein stability in dopaminergic neurons of the aging midbrain"],"prefix":"10.64898","author":[{"given":"Yongwoo","family":"Jang","sequence":"first","affiliation":[{"name":"Molecular Neurobiology Laboratory, Department of Psychiatry and Program in Neuroscience, McLean Hospital, Harvard Medical School, Belmont, MA 02478, USA"},{"name":"Department of Pharmacology, College of Medicine, Hanyang University, Seoul 04736, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Hwa","family":"Kim","sequence":"additional","affiliation":[{"name":"Molecular Neurobiology Laboratory, Department of Psychiatry and Program in Neuroscience, McLean Hospital, Harvard Medical School, Belmont, MA 02478, USA"},{"name":"Inflamm-Aging Translational Research Center, Ajou University Medical Center, Suwon 16499, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeha","family":"Jeon","sequence":"additional","affiliation":[{"name":"Molecular Neurobiology Laboratory, Department of Psychiatry and Program in Neuroscience, McLean Hospital, Harvard Medical School, Belmont, MA 02478, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young","family":"Cha","sequence":"additional","affiliation":[{"name":"Molecular Neurobiology Laboratory, Department of Psychiatry and Program in Neuroscience, McLean Hospital, Harvard Medical School, Belmont, MA 02478, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Lopes","sequence":"additional","affiliation":[{"name":"Molecular Neurobiology Laboratory, Department of Psychiatry and Program in Neuroscience, McLean Hospital, Harvard Medical School, Belmont, MA 02478, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Hyuk","family":"Jung","sequence":"additional","affiliation":[{"name":"Molecular Neurobiology Laboratory, Department of Psychiatry and Program in Neuroscience, McLean Hospital, Harvard Medical School, Belmont, MA 02478, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunji","family":"Oh","sequence":"additional","affiliation":[{"name":"Molecular Neurobiology Laboratory, Department of Psychiatry and Program in Neuroscience, McLean Hospital, Harvard Medical School, Belmont, MA 02478, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeongwon","family":"Park","sequence":"additional","affiliation":[{"name":"Molecular Neurobiology Laboratory, Department of Psychiatry and Program in Neuroscience, McLean Hospital, Harvard Medical School, Belmont, MA 02478, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chanyoung","family":"Ko","sequence":"additional","affiliation":[{"name":"Molecular Neurobiology Laboratory, Department of Psychiatry and Program in Neuroscience, McLean Hospital, Harvard Medical School, Belmont, MA 02478, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bobae","family":"Hyeon","sequence":"additional","affiliation":[{"name":"Molecular Neurobiology Laboratory, Department of Psychiatry and Program in Neuroscience, McLean Hospital, Harvard Medical School, Belmont, MA 02478, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Leblanc","sequence":"additional","affiliation":[{"name":"Molecular Neurobiology Laboratory, Department of Psychiatry and Program in Neuroscience, McLean Hospital, Harvard Medical School, Belmont, MA 02478, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwang-Soo","family":"Kim","sequence":"additional","affiliation":[{"name":"Molecular Neurobiology Laboratory, Department of Psychiatry and Program in Neuroscience, McLean Hospital, Harvard Medical School, Belmont, MA 02478, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"54368","reference":[{"key":"2026032600251325000_2026.03.19.712974v1.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tins.2007.03.006"},{"key":"2026032600251325000_2026.03.19.712974v1.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ydbio.2013.04.014"},{"key":"2026032600251325000_2026.03.19.712974v1.3","doi-asserted-by":"crossref","unstructured":"Maiti, P. , Manna, J. & Dunbar, G.L . Current understanding of the molecular mechanisms in Parkinson\u2019s disease: Targets for potential treatments. Transl Neurodegener 6, 28 (2017).","DOI":"10.1186\/s40035-017-0099-z"},{"key":"2026032600251325000_2026.03.19.712974v1.4","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2013.209"},{"key":"2026032600251325000_2026.03.19.712974v1.5","doi-asserted-by":"publisher","DOI":"10.1126\/science.276.5310.248"},{"key":"2026032600251325000_2026.03.19.712974v1.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2009.01.038"},{"key":"2026032600251325000_2026.03.19.712974v1.7","doi-asserted-by":"publisher","DOI":"10.1242\/dev.097394"},{"key":"2026032600251325000_2026.03.19.712974v1.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2005.09.001"},{"key":"2026032600251325000_2026.03.19.712974v1.9","doi-asserted-by":"crossref","unstructured":"Alavian, K.N. et al. The lifelong maintenance of mesencephalic dopaminergic neurons by Nurr1 and engrailed. J Biomed Sci 21, 27 (2014).","DOI":"10.1186\/1423-0127-21-27"},{"key":"2026032600251325000_2026.03.19.712974v1.10","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1221077110"},{"key":"2026032600251325000_2026.03.19.712974v1.11","doi-asserted-by":"publisher","DOI":"10.1002\/cne.10261"},{"key":"2026032600251325000_2026.03.19.712974v1.12","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.mad.2015.06.002","article-title":"Age-related gene expression changes in substantia nigra dopamine neurons of the rat","volume":"149","year":"2015","journal-title":"Mech Ageing Dev"},{"key":"2026032600251325000_2026.03.19.712974v1.13","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201404610"},{"key":"2026032600251325000_2026.03.19.712974v1.14","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3004676"},{"key":"2026032600251325000_2026.03.19.712974v1.15","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1046\/j.1471-4159.1999.02218.x","article-title":"Reduced Nurr1 expression increases the vulnerability of mesencephalic dopamine neurons to MPTP-induced injury","volume":"73","year":"1999","journal-title":"J Neurochem"},{"key":"2026032600251325000_2026.03.19.712974v1.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2011.11.024"},{"key":"2026032600251325000_2026.03.19.712974v1.17","doi-asserted-by":"publisher","DOI":"10.1042\/BJ20141293"},{"key":"2026032600251325000_2026.03.19.712974v1.18","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-med-051113-024537"},{"key":"2026032600251325000_2026.03.19.712974v1.19","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)71142-9"},{"key":"2026032600251325000_2026.03.19.712974v1.20","first-page":"e25025","article-title":"JAK2 mutants (e.g., JAK2V617F) and their importance as drug targets in myeloproliferative neoplasms","volume":"2","year":"2013","journal-title":"JAKSTAT"},{"key":"2026032600251325000_2026.03.19.712974v1.21","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1311347"},{"key":"2026032600251325000_2026.03.19.712974v1.22","doi-asserted-by":"publisher","DOI":"10.4161\/jkst.22925"},{"key":"2026032600251325000_2026.03.19.712974v1.23","doi-asserted-by":"publisher","DOI":"10.1517\/14728220903213426"},{"key":"2026032600251325000_2026.03.19.712974v1.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2011.05.011"},{"key":"2026032600251325000_2026.03.19.712974v1.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2012.12.030"},{"key":"2026032600251325000_2026.03.19.712974v1.26","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-4547(19981101)54:3<320::AID-JNR3>3.0.CO;2-R"},{"key":"2026032600251325000_2026.03.19.712974v1.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2014.03.036"},{"key":"2026032600251325000_2026.03.19.712974v1.28","doi-asserted-by":"publisher","DOI":"10.1111\/bph.12672"},{"key":"2026032600251325000_2026.03.19.712974v1.29","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2008.105"},{"key":"2026032600251325000_2026.03.19.712974v1.30","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M204610200"},{"key":"2026032600251325000_2026.03.19.712974v1.31","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.61.6474"},{"key":"2026032600251325000_2026.03.19.712974v1.32","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s40265-015-0351-8","article-title":"Ruxolitinib: a review of its use in patients with myelofibrosis","volume":"75","year":"2015","journal-title":"Drugs"},{"key":"2026032600251325000_2026.03.19.712974v1.33","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1517\/14656566.2014.913024","article-title":"Janus kinase inhibitors for the treatment of myeloproliferative neoplasms","volume":"15","year":"2014","journal-title":"Expert Opin Pharmacother"},{"key":"2026032600251325000_2026.03.19.712974v1.34","doi-asserted-by":"publisher","DOI":"10.1038\/s41589-020-0553-6"},{"key":"2026032600251325000_2026.03.19.712974v1.35","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1509742112"},{"key":"2026032600251325000_2026.03.19.712974v1.36","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-021-00555-5"},{"key":"2026032600251325000_2026.03.19.712974v1.37","doi-asserted-by":"crossref","unstructured":"Dodington, D.W. , Desai, H.R. & Woo, M . JAK\/STAT - Emerging Players in Metabolism. Trends Endocrinol Metab (2017).","DOI":"10.1016\/j.tem.2017.11.001"},{"key":"2026032600251325000_2026.03.19.712974v1.38","doi-asserted-by":"publisher","DOI":"10.1530\/JME-14-0308"},{"key":"2026032600251325000_2026.03.19.712974v1.39","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2016.04.200"},{"key":"2026032600251325000_2026.03.19.712974v1.40","first-page":"1","article-title":"Direct conversion from skin fibroblasts to functional dopaminergic neurons for biomedical application","volume":"1","year":"2017","journal-title":"Biomedical Dermatology"},{"key":"2026032600251325000_2026.03.19.712974v1.41","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwg068"},{"key":"2026032600251325000_2026.03.19.712974v1.42","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2004.08.035"},{"key":"2026032600251325000_2026.03.19.712974v1.43","first-page":"e1007","article-title":"Age-related changes in dopamine signaling in Nurr1 deficient mice as a model of Parkinson\u2019s disease","volume":"33","year":"2012","journal-title":"Neurobiol Aging"},{"key":"2026032600251325000_2026.03.19.712974v1.44","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M703753200"},{"key":"2026032600251325000_2026.03.19.712974v1.45","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2013.39"},{"key":"2026032600251325000_2026.03.19.712974v1.46","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.exger.2016.07.012","article-title":"Oxidative stress induces the decline of brain EPO expression in aging rats","volume":"83","year":"2016","journal-title":"Exp Gerontol"},{"key":"2026032600251325000_2026.03.19.712974v1.47","first-page":"393","article-title":"Role of the JAK2\/STAT pathway and losartan in human glomerular mesangial cell senescence","volume":"3","year":"2010","journal-title":"Mol Med Rep"},{"key":"2026032600251325000_2026.03.19.712974v1.48","first-page":"1248","article-title":"Facilitation of liver cancer SMCC7721 cell aging by sirtuin 4 via inhibiting JAK2\/STAT3 signal pathway","volume":"21","year":"2017","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2026032600251325000_2026.03.19.712974v1.49","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1093\/abbs\/gmw134","article-title":"JAK-STAT signaling mediates the senescence of bone marrow-mesenchymal stem cells from systemic lupus erythematosus patients","volume":"49","year":"2017","journal-title":"Acta Biochim Biophys Sin (Shanghai"},{"key":"2026032600251325000_2026.03.19.712974v1.50","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.4658-15.2016"},{"key":"2026032600251325000_2026.03.19.712974v1.51","doi-asserted-by":"crossref","unstructured":"Leblanc, P. et al. Production of Nurr-1 Specific Polyclonal Antibodies Free of Cross-reactivity Against Its Close Homologs, Nor1 and Nur77. J Vis Exp, e52963 (2015).","DOI":"10.3791\/52963-v"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.64898\/2026.03.19.712974","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T07:25:23Z","timestamp":1774509923000},"score":1,"resource":{"primary":{"URL":"http:\/\/biorxiv.org\/lookup\/doi\/10.64898\/2026.03.19.712974"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,23]]},"references-count":51,"URL":"https:\/\/doi.org\/10.64898\/2026.03.19.712974","relation":{},"subject":[],"published":{"date-parts":[[2026,3,23]]},"subtype":"preprint"}}